IAN SUDBURY: Open Payments
NPI 1316620131 · MILLCREEK, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$670 in 36 payments from 18 companies in 2025. Trend: 2023 $45 · 2024 $946 · 2025 $670
Food & beverage: $670
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $176 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $59 |
| PFIZER INC. | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Lilly USA, LLC | 2 | $34 |
| Novo Nordisk Inc | 2 | $34 |
| Medtronic, Inc. | 2 | $33 |
| SI-BONE, INC. | 1 | $21 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
Products named: UBRELVY, QULIPTA, NURTEC ODT, JARDIANCE, Auvelity, MOUNJARO, Ozempic, Symbravo.
Industry payments across UT — which companies pay providers there.
